These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11954054)

  • 81. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
    Wu SC; Lin YJ; Chou JW; Lin CW
    Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Predicting the kinetics of peptide-antibody interactions using a multivariate experimental design of sequence and chemical space.
    Andersson K; Choulier L; Hämäläinen MD; van Regenmortel MH; Altschuh D; Malmqvist M
    J Mol Recognit; 2001; 14(1):62-71. PubMed ID: 11180562
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [The influence of the FR-1 in heavy chain (VH) of antibodies on antibody secretion].
    Zhu LL; Li C; Li JD; Sun LN; Liang MF; Li DX
    Bing Du Xue Bao; 2008 May; 24(3):172-7. PubMed ID: 18683552
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.
    Heads JT; Adams R; D'Hooghe LE; Page MJ; Humphreys DP; Popplewell AG; Lawson AD; Henry AJ
    Protein Sci; 2012 Sep; 21(9):1315-22. PubMed ID: 22761163
    [TBL] [Abstract][Full Text] [Related]  

  • 85. VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates.
    Hugo N; Weidenhaupt M; Beukes M; Xu B; Janson JC; Vernet T; Altschuh D
    Protein Eng; 2003 May; 16(5):381-6. PubMed ID: 12826730
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Application of 13C NMR spectroscopy to paratope mapping for larger antigen-Fab complexes.
    Kim H; Kato K; Yamato S; Igarashi T; Matsunaga C; Ohtsuka H; Higuchi A; Nomura N; Noguchi H; Arata Y
    FEBS Lett; 1994 Jun; 346(2-3):246-50. PubMed ID: 8013642
    [TBL] [Abstract][Full Text] [Related]  

  • 87. IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design.
    Stoyle CL; Stephens PE; Humphreys DP; Heywood S; Cain K; Bulleid NJ
    Biochem J; 2017 Sep; 474(18):3179-3188. PubMed ID: 28784690
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.
    Watts NR; Cardone G; Vethanayagam JG; Cheng N; Hultgren C; Stahl SJ; Steven AC; Sällberg M; Wingfield PT
    J Mol Biol; 2008 Jun; 379(5):1119-29. PubMed ID: 18486949
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Force probe measurements of antibody-antigen interactions.
    Leckband DE; Kuhl TL; Wang HK; Müller W; Herron J; Ringsdorf H
    Methods; 2000 Mar; 20(3):329-40. PubMed ID: 10694455
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sequence determinants of protein aggregation in human VH domains.
    Dudgeon K; Famm K; Christ D
    Protein Eng Des Sel; 2009 Mar; 22(3):217-20. PubMed ID: 18957405
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structural and energetic hot-spots for the interaction between a ladder-like polycyclic ether and the anti-ciguatoxin antibody 10C9Fab.
    Ui M; Tanaka Y; Tsumuraya T; Fujii I; Inoue M; Hirama M; Tsumoto K
    Mol Biosyst; 2011 Mar; 7(3):793-8. PubMed ID: 21161086
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins.
    Laune D; Molina F; Ferrieres G; Mani JC; Cohen P; Simon D; Bernardi T; Piechaczyk M; Pau B; Granier C
    J Biol Chem; 1997 Dec; 272(49):30937-44. PubMed ID: 9388240
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation study.
    Wang T; Duan Y
    Protein Eng Des Sel; 2011 Sep; 24(9):649-57. PubMed ID: 21729946
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunoglobulin structure.
    Virella G; Wang AC
    Immunol Ser; 1993; 58():75-90. PubMed ID: 8424994
    [No Abstract]   [Full Text] [Related]  

  • 95. Cooperative effects of mutations in a recombinant Fab on the kinetics of antigen binding.
    Rauffer-Bruyre N; Chatellier J; Weiss E; Van Regenmortel MH; Altschuh D
    Mol Immunol; 1997 Feb; 34(2):165-73. PubMed ID: 9188849
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Determinants of the assembly and function of antibody variable domains.
    Herold EM; John C; Weber B; Kremser S; Eras J; Berner C; Deubler S; Zacharias M; Buchner J
    Sci Rep; 2017 Sep; 7(1):12276. PubMed ID: 28947772
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reengineering immunoglobulin domain interactions by introduction of charged residues.
    Raffen R; Stevens PW; Boogaard C; Schiffer M; Stevens FJ
    Protein Eng; 1998 Apr; 11(4):303-9. PubMed ID: 9680192
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Functional maturation of the human antibody response to rotavirus.
    Kallewaard NL; McKinney BA; Gu Y; Chen A; Prasad BV; Crowe JE
    J Immunol; 2008 Mar; 180(6):3980-9. PubMed ID: 18322207
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hv(1), a variable-region genetic marker of human immunoglobulin heavy chains.
    Wang AC; Mathur S; Pandey J; Siegel FP; Middaugh CR; Litman GW
    Science; 1978 Apr; 200(4339):327-9. PubMed ID: 416494
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Proceedings: Immunochemistry of tobacco mosaic virus (TMV). Determination of association constants of Fab fragments].
    van Regenmortel MH; Hardie G
    Ann Immunol (Paris); 1975 Apr; 126(3):363. PubMed ID: 1180499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.